|
1
|
Lung FW, Lee TM, Shu BC and Chang FH: p53
codon 72 polymorphism and susceptibility malignancy of colorectal
cancer in Taiwan. J Cancer Res Clin Oncol. 130:728–732. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Furihata M, Kurabayashl A, Matsumoto M, et
al: Frequent phosphorylation at serine 392 in overexpressed p53
protein due to missense mutation in carcinoma of the urinary tract.
J Pathol. 197:82–88. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen WC, Tsai FJ, Wu JY, Wu HC, Lu HF and
Li CW: Distributions of p53 codon 72 polymorphism in bladder cancer
- proline form is prominent in invasive tumor. Urol Res.
28:293–296. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin H, Huang CH, Yu TJ, Wu WJ, Yang MC and
Lung FW: p53 codon 72 polymorphism was associated with
vulnerability, progression, but not prognosis of bladder cancer in
Taiwanese population: an implication of structural equation
modeling to manage risks of bladder cancer. Urol Int. 86:355–360.
2011. View Article : Google Scholar
|
|
5
|
Li CC, Chang TH, Wu WJ, et al: Significant
predictive factors for prognosis of primary upper urinary tract
cancer after radical nephroureterectomy in Taiwanese patients. Eur
Urol. 54:1127–1134. 2008. View Article : Google Scholar
|
|
6
|
Chen YC, Xu L, Guo YL, et al:
Polymorphisms in GSTT1 and p53 and urinary transitional cell
carcinoma in south-western Taiwan: a preliminary study. Biomarkers.
9:386–394. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin HY, Huang CH, Wu WJ, et al: Mutation
of the p53 tumor suppressor gene in transitional cell carcinoma of
the urinary tract in Taiwan. Kaohsiung J Med Sci. 21:57–64. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dumont P, Leu JI, Della Pietra AC III,
George DL and Murphy M: The codon 72 polymorphic variants of p53
have markedly different apoptotic potential. Nat Genet. 33:357–365.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pim D and Banks L: p53 polymorphic
variants at codon 72 exert different effects on cell cycle
progression. Int J Cancer. 108:196–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siddique M and Sabapathy K:
Trp53-dependent DNA-repair is affected by the codon 72
polymorphism. Oncogene. 25:3489–3500. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuroda Y, Nakao H, Ikemura K and Katoh T:
Association between the TP53 codon72 polymorphism and oral cancer
risk and prognosis. Oral Oncol. 43:1043–1048. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Soulitzis N, Sourvinos G, Dokianakis DN
and Spandidos DA: p53 codon 72 polymorphism and its association
with bladder cancer. Cancer Lett. 179:175–183. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tada M, Furuuchi K, Kaneda M, et al:
Inactivate the remaining p53 allele or the alternate p73?
Preferential selection of the Arg72 polymorphism in cancers with
recessive p53 mutants but not transdominant mutants.
Carcinogenesis. 22:515–517. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Storey A, Thomas M, Kalita A, et al: Role
of a p53 polymorphism in the development of human
papillomavirus-associated cancer. Nature. 393:229–234. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park JS, Kim EJ, Lee JY, Sin HS, Namkoong
SE and Um SJ: Functional inactivation of p73, a homolog of p53
tumor suppressor protein, by human papillomavirus E6 proteins. Int
J Cancer. 91:822–827. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Horikawa Y, Nadaoka J, Saito M, et al:
Clinical implications of the MDM2 SNP309 and p53 Arg72Pro
polymorphisms in transitional cell carcinoma of the bladder. Oncol
Rep. 20:49–55. 2008.PubMed/NCBI
|
|
17
|
Falagas ME, Zarkadoulia EA, Ioannidou EN,
Peppas G, Christodoulou C and Rafailidis PI: The effect of
psychosocial factors on breast cancer outcome: a systematic review.
Breast Cancer Res. 9:R442007. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gidron Y and Ronson A: Psychosocial
factors, biological mediators, and cancer prognosis: a new look at
an old story. Curr Opin Oncol. 20:386–392. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghaemi SN: A Clinician's Guide to
Statistics and Epidemiology in Mental Health. Cambridge University
Press; Cambridge: 2009
|
|
20
|
Boldrini L, Gisfredi S, Ursino S, et al:
Effect of the p53 codon 72 and intron 3 polymorphisms on non-small
cell lung cancer (NSCLC) prognosis. Cancer Invest. 26:168–172.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang W, Jin MJ and Chen K: Association of
p53 polymorphisms and its haplotypes with susceptibility of breast
cancer. Zhejiang Da Xue Xue Bao Yi Xue Ban. 36:561–566.
2007.PubMed/NCBI
|
